Search results for "Vaccinations"


 
Results 161 - 170 of about 329 for "Vaccinations".
Sort by: Relevance | Newest | Oldest

Breakthrough infections, cardiovascular effects of COVID-19, pandemic mental health

Two new studies reported on infections in fully vaccinated people, while another looked at the rate of myocardial infarction and stroke in patients with COVID-19. A survey found depression and anxiety to be common during the pandemic, and the push for mandatory vaccination of health care workers continued.
https://immattersacp.org/weekly/archives/2021/08/03/4.htm
3 Aug 2021

New data on COVID-19 vaccines' effectiveness against omicron, among immunocompromised

One English analysis showed how COVID-19 boosters increase protection against symptomatic infection from omicron, while two studies looked at vaccinating the immunocompromised, and ACP videos worked to educate patients and increase vaccine uptake.
https://immattersacp.org/weekly/archives/2022/03/08/2.htm
8 Mar 2022

CDC reports on safety after month of COVID-19 vaccines, ACIP updates vaccine schedule

The 2021 schedule from the Advisory Committee on Immunization Practices (ACIP) includes interim recommendations for COVID-19 vaccination, as well as updates for vaccines against influenza, hepatitis A, and others.
https://immattersacp.org/weekly/archives/2021/02/23/3.htm
23 Feb 2021

More booster authorizations, research on vaccine safety and uptake

The FDA and CDC endorsed boosters of the Johnson & Johnson and Moderna vaccines. Recent research showed that COVID-19 vaccination was not associated with miscarriage, and a small financial incentive for receiving a COVID-19 vaccine or providing transportation to a vaccination site increased uptake.
https://immattersacp.org/weekly/archives/2021/10/26/1.htm
26 Oct 2021

ACP issues policy statement on global COVID-19 vaccine distribution and allocation

The College's statement stresses that physicians have a responsibility to advocate for the health and well-being of patients and communities locally and globally and calls for a coordinated global vaccination effort to be ethical as well as practical.
https://immattersacp.org/weekly/archives/2021/06/22/2.htm
22 Jun 2021

New COVID-19 vaccine authorized; reviews analyze myocarditis, drug treatments

The FDA gave the Novavax COVID-19 vaccine emergency use authorization for adults. One recent review found lower myocarditis risk with the Pfizer-BioNTech vaccine than the Moderna vaccine, and another looked at the strength of evidence supporting COVID-19 drug treatments.
https://immattersacp.org/weekly/archives/2022/07/19/4.htm
19 Jul 2022

Racial, ethnic disparities persist in U.S. health care access, spending

Recent studies looked at differences by race and ethnicity in quality of ambulatory care for patients with Medicare Advantage versus traditional Medicare, health status and health care access, and health care spending over time.
https://immattersacp.org/weekly/archives/2021/08/24/4.htm
24 Aug 2021

News on booster doses and omicron, COVID-19 and women's health, outpatient treatments

Recipients of mRNA COVID-19 vaccines are now eligible for boosters at five months, the CDC released additional data on vaccine safety in pregnancy, a study found a short-term association between COVID-19 vaccination and menstrual changes, and new outpatient treatments were authorized.
https://immattersacp.org/weekly/archives/2022/01/11/1.htm
11 Jan 2022

New ACIP Adult Immunization Schedule recommends changes to herpes zoster, pneumococcal, hepatitis B vaccines

The guidelines from the CDC's Advisory Committee on Immunization Practices (ACIP) also include information on COVID-19 vaccines, stressing that it is safe to co-administer them with other vaccines.
https://immattersacp.org/weekly/archives/2022/02/22/2.htm
22 Feb 2022

Nirmatrelvir/ritonavir rarely leads to rebound, doesn't help average-risk patients, studies find

A retrospective analysis found that symptom rebound occurred in less than 1% of high-risk COVID-19 patients treated with nirmatrelvir/ritonavir, while the manufacturer reported that the drug didn't show significant benefit in average-risk patients.
https://immattersacp.org/weekly/archives/2022/06/21/2.htm
21 Jun 2022

Result Page: Prev   12   13   14   15   16   17   18   19   20   21   Next